Pharmacology of Adjuvant Hormonotherapy in Breast Cancer

Exclusion Criteria

• •1. Patient previously treated for breast cancer receiving hormonal therapy with tamoxifen, anastrozole, letrozole or exemestane regardless of the scheme
• •2. Metastatic Breast cancer
• •3. History of another cancer diagnosed within 5 years before or uncontrolled except carcinoma in situ of cervix carcinoma, nonmelanoma skin, breast cancer (in this case, treatment with hormone therapy should be stopped for at least 6 months)
• •4. Any other medical or psychiatric condition or laboratory abnormality severe acute or chronic making the inclusion of the patient in the study inappropriate in the opinion of the investigator
• •5. Patient unable to follow procedures, visits, examinations described in the study
• •6. Pregnant women or nursing mothers can not participate in the study
• •7. Women of childbearing age must use effective contraception at study entry and up to at least three months after the end of treatment
• •8. Patient under legal guardianship